
The Acceleration of Personalized Medicine
550 executives exploring pharmacogenetics, genomic medicine and the shift from sick care toward personalized healthcare.
From sick care to predictive, personalized, connected healthcare.
For more than three decades, Jim Carroll has helped healthcare systems, pharmaceutical companies, medical-device leaders, pharmacy organizations, clinicians and life-science executives understand the accelerating science and technology reshaping medicine.
Long before “digital health,” “the empowered patient,” telemedicine or online medical misinformation became mainstream issues, Jim Carroll and Rick Broadhead wrote Good Health Online: A Wellness Guide for Every Canadian.
The book explored how ordinary people would use networked medical information, how the doctor-patient relationship would change, why information quality mattered, and how healthcare organizations would have to adapt to increasingly informed patients.
Nearly three decades later, Jim still uses it as an early marker of a career-long healthcare thesis: medicine would become more connected, more information-rich, more personalized and more participatory.

Jim has been using this framing for decades: the system shifts from reacting after illness appears toward predicting, preventing and managing conditions earlier through genomics, diagnostics, data and connected care.
Genomics, AI and continuous data improve the ability to identify risk before symptoms appear.

Care moves upstream toward wellness, diagnostics, adherence and earlier intervention.

Medicine moves from the average patient toward treatment based on individual biology, response and context.

Hospital leaders, pharma executives, pharmacists, clinicians and medical-device organizations do not need the same speech.
A new operating system for a data-driven, predictive world.
Diagnostics, clinical decisions, discovery and the algorithmic medical partner.
Genomics, pharmacogenetics and patient-of-one care.
Bio-connectivity, virtual care and the extension of care into the home.
From dispensing pills to diagnostics, community care and digital therapeutics.
How to lead when knowledge and capability move faster than institutions.
From e-health and electronic records to genomics, connected devices, AI clinical trials and precision medicine.
Empowered patients, EHR, healthcare IT, risk, supply chain, diagnostics and medical knowledge growth.
Preventative genomic medicine, virtual care, retail health, just-in-time knowledge and system redesign.
Pharmacogenetics, connected devices, 3D medical materials, new pharmacy roles and accelerating science.
Pfizer, PhRMA, Genentech, post-pandemic healthcare, digital therapeutics and remote monitoring.
AI-enabled clinical trials, algorithmic diagnostics, patient-of-one medicine and continuous physiological data.
Healthcare is being reshaped by multiple forces arriving together rather than one isolated technology.
Move from fixing people after they are sick toward earlier prediction and intervention.
Gene therapy, regenerative medicine, biomaterials and rapidly expanding knowledge.
Wearables, implantables, remote monitoring and hospital-level care beyond hospital walls.
Patients increasingly arrive with data, research, expectations and digital tools.
Imaging, decision support, treatment planning and clinical workflow augmentation.
Episodic measurement gives way to continuous health intelligence.
Hyper-specialization creates demand for the right knowledge at the right moment.
Pharmacy expands into community care, diagnostics, vaccines and integrated health services.
The focus shifts from simply extending lifespan toward extending healthy life.
Tech, insurance, food, devices, pharma and healthcare increasingly overlap.
Medical knowledge has moved from a world where doubling took years toward a world where the knowledge base can expand in months.
The strategic challenge is no longer simply what clinicians know. It is how effectively a healthcare system gets the right knowledge to the right professional at the right time.


Care does not disappear. The walls do. Connected medical devices, telehealth, remote monitoring and home diagnostics extend healthcare into the community and home.
The future hospital becomes as much a network as a place.
AI increasingly supports image interpretation, diagnostic reasoning, drug discovery, trial design, documentation and treatment planning.
The opportunity is not to replace the clinician. It is to give the clinician access to a level of pattern recognition and knowledge no human can carry alone.


Genomics and pharmacogenetics shift treatment from mass-market averages toward therapies designed for specific genetic profiles and biological pathways.
The drug-development system also becomes increasingly computational: candidate molecules, patient recruitment, response prediction and clinical-trial design are all targets for AI acceleration.
Jim has been discussing the expansion of pharmacy since the early 2000s, often using MinuteClinic as an early sign that routine healthcare would move into retail settings.
Vaccination, diagnostics, medication management, chronic-care support, digital therapeutics and community health services expand the pharmacist's role far beyond dispensing.


Genomic sequencing, pharmacogenomics, biomarkers, AI and continuous monitoring create an increasingly individualized model of medicine.
The patient becomes a dataset of one.
Regenerative medicine, brain science, gene therapy, biomaterials and earlier diagnostics shift the healthcare agenda toward extending the years people can live with meaningful health.


New therapies, AI systems, connected devices, data dependence, cybersecurity and rapidly changing standards create risk categories that did not exist when many current governance models were designed.
Risk management must accelerate with the science.
From the information-empowered patient to predictive genomic medicine, many of the structural calls have become the operating reality.
Patients use networked information and change the clinical relationship.
Healthcare shifts from react-and-repair toward predict-and-prevent.
Virtual care, bio-connectivity and community-oriented delivery.
Community pharmacy becomes a larger part of preventative healthcare.
AI accelerates candidate selection, trial enrollment and response prediction.
A sampling of the pharma, medical, dental and healthcare organizations Jim has worked with.











More client logos being added.
Pharma leadership, hospital CEOs, medical associations, device companies and pharmacy groups each require a different future story.

550 executives exploring pharmacogenetics, genomic medicine and the shift from sick care toward personalized healthcare.

Bionic limbs, 3D printed body parts, new materials and connected medical devices for more than 500 executives.

Scientific acceleration, medical transformation and the opportunities emerging from rapidly changing healthcare.

Hospital CEOs and senior leaders focused on genomics, virtual care, just-in-time knowledge, consumerization and system innovation.
For strategy meetings, scientific leadership sessions and highly customized industry events.
Global leadership on genomics, gene therapy, medical-device connectivity, patient-doctor change and exploding medical knowledge.
CEO-led strategy meeting on AI in pharmaceutical development and clinical trials, including patient recruitment and response prediction.
Scientific and technological trends redefining healthcare and biopharmaceutical research.
Genomics, surgical innovation, connected devices, accelerating science and the future of orthopaedic technology.
Bio-connected devices, virtualization of healthcare, big data and analytics.
Supply chain meets digital health, community pharmacy transformation and the changing role of pharmaceutical distribution.
Using health-sector feedback rather than recycling the same general testimonials.
“The best speaker we've ever had, bar none!”PhRMA • 2019
“You were phenomenal... wow the feedback on your session has been fantastic!”ICON plc • CEO-led AI strategy event
“A stunning keynote with extremely powerful insight. Humour, energy, deep research and relevant content for our audience. We loved him!”Client event feedback
“Revenue reinvention. The acceleration of science. The transformation of industry. I could barely keep up with the blistering pace of the change that is coming at us.”Client leadership feedback
A pharma R&D team, a hospital board, pharmacists and medical-device executives need different trend maps.
Scientific literature, market data, clinical technology, company strategy, event objectives, stakeholder calls and current developments. Jim builds the story around the specific medical or healthcare context in the room.
LISTEN → RESEARCH → MAP THE SCIENCE → BUILD THE STORY → CONNECT THE ROOM → LEAVE A PLAYBOOK
Pharmaceuticals, biotech, hospitals, medicine, devices, pharmacy, dental, veterinary and wellness.
Pharma & biotech: Pfizer • PhRMA • Genentech • Roche • Boehringer Ingelheim • Emergent BioSolutions • ICON plc • World Pharma Congress • Celgene / Sentrix
Hospitals & health systems: Ontario Hospital Association • Minnesota Hospital Association • Pennsylvania Hospital Association • Mercy Health • St. Joseph’s Healthcare • Greater Lansing HealthCare • Providence Health
Medical devices & supplies: Stryker • Philips Medical Devices • Henry Schein • MDS Nordion • Roche Diagnostics
Pharmacy & distribution: McKesson • National Pharmacy Forum • NCPDP • PCCA • HIDA • Consorta • CAPDM
Medical associations: American Medical Association • American Association of Orthopaedic Executives • American Academy of Ophthalmology • American Dental Association • AHCA
Dental & veterinary: Invisalign / Align Technology • Cain Watters • Ontario Dental Association • NADL • Patterson Veterinary • NAVC
Health plans & wellness: Magellan Health • Anthem • Highmark Health • New York Health Plans Association • Blue Cross / Blue Shield • Benefiq.
Tell Jim who is in the room and where you sit in the healthcare ecosystem. He will help shape a keynote around the scientific, technology, workforce and leadership issues that matter most.
Hospital? Pharma? Pharmacy? Device? Medical association? Health plan?
AI, genomics, pharmacy, virtual care, science acceleration or leadership.
Stakeholder calls, scientific research, industry-specific trends and event integration.
Timing, format, fees, travel, logistics and the best next step.
Jim is always pleased to jump on a quick exploratory Zoom or phone call to learn about the audience and discuss the best direction.
Contact JimGrab the PDF